Shareholding disclosure

IFM Independent Fund Management AG

Declared position

2.97%

Threshold

Crossed upwards

Timeline

Published

06.02.2018

Transaction

19.01.2018

Voting rights breakdown

Voting rights acquired2.97%

Voting rights sold0%

Below threshold0%

Notice details

CategoryCollective investment vehicle

ExchangeXSWX

Notification ID

TCI2200018

Beneficial owner

IFM Independent Fund Management AG

Declared address

IFM Independent Fund Management AG, 9490

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

IFM Independent Fund Management AG

Addex Therapeutics Ltd06.02.2018TCI2200018

Disclosure summary

IFM Independent Fund Management AG disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 06.02.2018, at 2.97% of voting rights. Notice category: Collective investment vehicle.

Disclosed position

2.97%

Voting rights acquired

Voting rights acquired2.97%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

IFM Independent Fund Management AG disclosed a holding in Addex Therapeutics Ltd, published on 06.02.2018.

Publication date06.02.2018

Transaction date19.01.2018

Issuing companyAddex Therapeutics Ltd

Beneficial ownerIFM Independent Fund Management AG

Declared addressIFM Independent Fund Management AG, 9490

CategoryCollective investment vehicle

Voting rights acquired2.97%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTCI2200018

Source: SIX Exchange Regulation · Publication date: 06.02.2018

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open